Table 3. Operative characteristics.
Characteristics | Myxomas (n=99) | Other benign tumours (n=8) | Malignant tumours (n=8) | P value |
---|---|---|---|---|
Surgical time, min | 195.7±59.4 | 182.6±43.3 | 249.1±50.6 | 0.035 |
CPB time, min | 89.4±44.4 | 75.6±39.4 | 115.5±33.7 | 0.167 |
Cross-clamp time, min | 58.7±35.8 | 43.5±30.7 | 65.4±34.4 | 0.425 |
Concomitant procedures | ||||
MVR | 0 (0%) | 1 (12.5%) | 2 (25.0%) | 0.479 |
MVP | 31 (31.3%) | 0 (0%) | 1 (12.5%) | 0.099 |
TVP | 50 (50.5%) | 2 (25.0%) | 4 (50.0%) | 0.384 |
Ablation | 3 (3.0%) | 0 (0%) | 0 (0%) | 0.781 |
CABG | 9 (9.1%) | 1 (12.5%) | 1 (12.5%) | 0.912 |
Time to extubation, h | 12.8±9.0 | 12.5±6.1 | 26.8±55.1 | 0.068 |
ICU time, h | 80.8±71.8 | 65.5±49.4 | 123.6±120.8 | 0.240 |
Postoperative hospitalization time, d | 10.3±4.0 | 12.5±2.9 | 14.8±6.1 | 0.009 |
30-day mortality | 0 (0%) | 0 (0%) | 2 (25%) | 0.683 |
CPB, cardiopulmonary bypass; MVR, mitral valve repair; MVP, mitral valve plasty; TVP, tricuspid valve plasty; CABG, coronary artery bypass graft.